These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2665980)

  • 61. [Cutaneous pyoderma gangrenosum with hepatosplenic localization and monoclonal gammapathy. A case report].
    Delbrel X; Germain P; Fach J; Etienne G; Beylot C; Parrens M; De Mascarel A; Le Bras M; Longy-Boursier M
    Ann Med Interne (Paris); 2001 Feb; 152(1):65-7. PubMed ID: 11240430
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Hepatic disorders in late cutaneous porphyria].
    Gheorghiu G; Vasiliu I; Forsea D
    Stud Cercet Med Interna; 1969; 10(3):239-49. PubMed ID: 5345224
    [No Abstract]   [Full Text] [Related]  

  • 63. Hepatic disease and the skin.
    Berman JE; Lamkin BC
    Dermatol Clin; 1989 Jul; 7(3):435-48. PubMed ID: 2665980
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cutaneous manifestations of liver diseases.
    Ghosn SH; Kibbi AG
    Clin Dermatol; 2008; 26(3):274-82. PubMed ID: 18640524
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Skin manifestations of systemic disease.
    Lee A
    Aust Fam Physician; 2009 Jul; 38(7):498-505. PubMed ID: 19575068
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dermatologic disorders and the liver.
    Satapathy SK; Bernstein D
    Clin Liver Dis; 2011 Feb; 15(1):165-82. PubMed ID: 21111999
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Skin and the liver].
    Ippen H
    Z Haut Geschlechtskr; 1971 Oct; 46(19):567-9. PubMed ID: 4944719
    [No Abstract]   [Full Text] [Related]  

  • 68. [Clinical aspects of porphyria hepatocutaneous tarda].
    Schüller Pérez A
    An R Acad Nac Med (Madr); 1987; 104(4):538-51. PubMed ID: 3328527
    [No Abstract]   [Full Text] [Related]  

  • 69. Dermatologic manifestations of rheumatic disorders.
    McCauliffe DP; Sontheimer RD
    Prim Care; 1993 Dec; 20(4):925-41. PubMed ID: 8310089
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatic, ocular, and cutaneous sarcoidosis.
    Rose AS; Tielker MA; Knox KS
    Clin Chest Med; 2008 Sep; 29(3):509-24, ix. PubMed ID: 18539241
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
    Wasmuth HE; Lammert F; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cognition in liver disease.
    Collie A
    Liver Int; 2005 Feb; 25(1):1-8. PubMed ID: 15698392
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gastrointestinal manifestations of skin diseases: a review.
    Kubba R
    Trop Gastroenterol; 1983; 4(2):67-78. PubMed ID: 6356528
    [No Abstract]   [Full Text] [Related]  

  • 74. HIV-Related hepatic disease: when and why to biopsy.
    Poles MA
    Gastrointest Endosc Clin N Am; 1998 Oct; 8(4):939-62. PubMed ID: 9730941
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.